Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the surge in pharma M&A in 2025, ACA ...

The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

Jarez Holz says 2026 will be a strong year for biotech stocks. The Mizuho analyst explained why in a recent CNBC interview.

Small and mid-cap biotech stocks entered 2025 like a compressed spring, and it finally snapped higher— here's why.

C4 Therapeutics Inc. (NASDAQ: CCCC) is one of the best biotech penny stocks to buy according to analysts. On December 17, ...

According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...

A life-sciences job in Boston used to be a sure path to a high-paying career, but empty labs and unemployed grads now herald ...

Compare the 2026 BSc Microbiology and BSc Biotechnology. To help you choose between a career in genetic engineering and ...

As 2025 ends, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling ...

Here’s what was behind the recent sale of a former San Rafael biotech facility, a Santa Rosa distiller’s cautiously bold sublease, a Santa Rosa eye treatment center relocation, a San Rafael ...

O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

Sameer Abdullah, Chief Executive Officer of Biotech Medical, has been honored with the prestigious FLUXX USA Award 2025, recognizing his exceptional leadership ...